Pioglitazone: PPARγ Agonist for Type 2 Diabetes and Infla...
2026-01-19
Pioglitazone is a selective peroxisome proliferator-activated receptor gamma (PPARγ) agonist, widely used for studies in type 2 diabetes mellitus and immunometabolic mechanisms. Its validated efficacy in modulating macrophage polarization and reducing inflammation makes it a benchmark research tool. This article details atomic facts, current evidence, and optimal integration parameters for laboratory use.